SKLB-C-2211

N/A

Report date: 2022/07/01 15:29:28
NME

Base Information

Drug NameSKLB-C-2211
Drug Alias NameSKLB-C-2211SKLB-C2211
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSmoothened receptor antagonists
TargetsSmoothened receptor
Therapy Area/IndicationsCarcinoma, Basal Cell
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesSichuan University
China Registration ClassN/A

Develop Information

Active CompaniesSichuan University
Inactive CompaniesN/A
Active IndicationsCarcinoma, Basal Cell
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A